Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab

Nivolumab is one of the most commonly used monoclonal antibodies for advanced non-small cell lung cancer treatment, to the extent that the presence of its anti-antibody is considered a negative prognostic factor. Vitamin D (VD) modulates expression of the genes involved in drug metabolism and elimin...

Full description

Bibliographic Details
Main Authors: Jessica Cusato, Carlo Genova, Cristina Tomasello, Paolo Carrega, Selene Ottonello, Gabriella Pietra, Maria Cristina Mingari, Irene Cossu, Erika Rijavec, Anna Leggieri, Giovanni Di Perri, Maria Giovanna Dal Bello, Simona Coco, Simona Boccardo, Guido Ferlazzo, Francesco Grossi, Antonio D’Avolio
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Cancers
Subjects:
monoclonal antibody
NSCLC
immunotherapy
ELISA
pharmacokinetics
pharmacogenetics
Online Access:https://www.mdpi.com/2072-6694/11/1/125

Internet

https://www.mdpi.com/2072-6694/11/1/125

Similar Items